相关实验视频
Updated: Jul 9, 2025

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
胃食道逆流和PPI暴露改变了非常年幼的婴儿的肠道微生物群
Denease Francis1, Anupama Chawla2, Joseph F LaComb2
1Department of Pediatrics, Texas Tech University Health Sciences Center El Paso, El Paso, TX, United States.
患有胃食道逆流的婴儿用质子抑制剂 (PPI) 治疗改变了肠道微生物群的多样性,并增加了某些细菌. 这项研究强调了PPI对婴儿肠道微生物组成的影响.
科学领域:
- 微生物学 微生物学
- 儿科 儿科 儿科
- 胃肠病学 胃肠病学
背景情况:
- 患有症状胃食道逆流的婴儿通常接受质子抑制剂 (PPI) 来缓解症状.
- 对于PPI治疗对婴儿肠道微生物群的影响尚不清楚.
研究的目的:
- 研究PPI治疗对婴儿肠道细菌丰富性,多样性和特定种群的影响.
- 将PPI治疗的婴儿的肠道微生物组与未接受酸抑制治疗的婴儿进行比较.
主要方法:
- 在Stony Brook医院从2016年2月到2019年6月进行了一项队列研究.
- 来自58名婴儿的便样本 (29名接受PPI治疗,29名健康对照) 被分析了微生物组合.
主要成果:
- 两组之间观察到阿尔法和β多样性的显著差异.
- 接受PPI治疗的婴儿表现出Firmicutes的相对丰度增加,而对照组则由Bifidobacterium主导.
- PPI暴露的持续时间与肠道微生物多样性和丰度的变化相关.
结论:
- PPI疗法显著改变婴儿肠道微生物群,增加细菌种类和多样性.
- 暴露于PPI会导致婴儿肠道微生物组的早期丰富.
- 这些发现强调了在婴儿中使用PPI时需要考虑微生物组的变化.
更多相关视频
09:20Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
相关概念视频
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...